Siti Internazionali
Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.
Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.
In evidenza
In evidenza
PressRelease
Japan’s CBD Industry Recieves First Investments From Publicly Listed Companies Following
PressRelease
Responsabilità editoriale di news aktuell
- RIPRODUZIONE RISERVATA
PressRelease - Responsabilità editoriale di news aktuell
AstraSana Japan Co., Ltd. has formed a capital and business alliance with Japan’s GSI Creos Corporation, bolstered by their investment. This partnership will enhance the wholesale distribution of CBD raw materials across Japan, leveraging the strengths of both companies.
Through this alliance, the AstraSana Group, headquartered in Switzerland, will establish a robust supply chain to deliver Swiss-made, high-quality CBD raw materials across Japan, with a mission is to ensure customers receive safe, reliable products of the highest standard.
Through this alliance, AstraSana Group (headquartered in Switzerland) will establish a stable supply chain to deliver Swiss-made, high-quality CBD raw materials nationwide in Japan. We aim to provide safe and reliable products to our customers.
By leveraging GSI Creos’ extensive resources and networks, AstraSana says it will offer even higher-quality services to customers. Based on this robust partnership, it will actively contribute to the growth and development of the CBD market through various approaches.
“At AstraSana Japan, we prioritize safety through third-party analyses, ensure the delivery of superior-quality products, and place customer trust and satisfaction at the heart of everything we do. We are dedicated to enhancing customers’ ‘Quality of Life’ (QOL) while staying at the forefront of technological innovation.
The Potential of CBD in the Japanese Market
CBD (Cannabidiol), a hemp-derived compound, is legally recognized as a safe material in Japan. With global demand on the rise, the opportunities for CBD in the Japanese market are rapidly expanding. This collaboration strengthens AstraSana’s supply chain, addressing past challenges, and further promotes the availability of safe and reliable CBD products across the country.
About GSI Creos Corporation
Website: GSI Creos Corporation
GSI Creos is an innovative trading company with nine domestic and 24 international bases. Operating globally in both “textiles” and “industrial products,” their business spans a diverse range, including textile raw materials, apparel, chemicals, hobby materials, machinery, semiconductor components, and nanotechnology. Guided by the purpose, “Creating quality of life for the next generation,” GSI Creos champions ESG management to tackle social challenges and promote human well-being.
About AstraSana Group / AstraSana Holding AG
Website: AstraSana Holding AG
The AstraSana Group is a leading global company specializing in cannabinoid raw materials and medical cannabis. Headquartered in Zurich, Switzerland, AstraSana Holding AG operates through affiliates in the Czech Republic, the UK, and Japan. Collaborating with partners across Europe and South America, including Belgium, the group continues to expand its worldwide presence.
Yves Antoniazzi
info@astrasana.com
PressRelease - Responsabilità editoriale di news aktuell
Ultima ora
Ultima ora